Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta] (2011)
- Autores:
- Autor USP: EVORA, PAULO ROBERTO BARBOSA - FMRP
- Unidade: FMRP
- Assuntos: CARDIOPATIAS; FEBRE REUMÁTICA; EDEMA PULMONAR
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: International Journal of Cardiology
- ISSN: 0167-5273
- Volume/Número/Paginação/Ano: v. 151, n. 3, p. 365-366, 2011
-
ABNT
EVORA, Paulo Roberto Barbosa et al. Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta]. International Journal of Cardiology. Co-Clare: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 20 abr. 2024. , 2011 -
APA
Evora, P. R. B., Evora, P. M., Capellini, V. K., & Celotto, A. C. (2011). Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta]. International Journal of Cardiology. Co-Clare: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Evora PRB, Evora PM, Capellini VK, Celotto AC. Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta]. International Journal of Cardiology. 2011 ; 151( 3): 365-366.[citado 2024 abr. 20 ] -
Vancouver
Evora PRB, Evora PM, Capellini VK, Celotto AC. Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta]. International Journal of Cardiology. 2011 ; 151( 3): 365-366.[citado 2024 abr. 20 ] - Budd-chiari syndrome in a 25-year-old woman with behçet's disease: a case report and review of the literature
- Endothelium dysfunction classification [Carta]: keeping the discussion opened
- Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]
- Effect of the chronic metabollic acidosis on rat thoracic aorta reactivity
- Evolution of the Brazilian Journal of Cardiovascular Surgery [Editorial]
- Vasopressor support sparing strategies [Editorial]: a concept to be incorporated as a paradigm in the treatment of vasodilatory shock
- Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…"
- Presentation of an experimental method to induce in vitro ("organ chambers") respiratory acidosis and its effects on vascular reactivity
- Possible advances in vasopressors and inotropes support in shock. [Carta]
- Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
